Ressources numériques en sciences humaines et sociales OpenEdition Nos plateformes OpenEdition Books OpenEdition Journals Hypothèses Calenda Bibliothèques OpenEdition Freemium Suivez-nous

RegenMedEd roundtable with FDA’s office of therapeutic products (OTP) (from Catapult’s regulatory round-up for December 2024)

The FDA’s Center for Biologics Evaluation and Research (CBER), OTP will be hosting a webinar on 30th January 2025 which is part of an educational series, RegenMedEd. This series aims to provide foundational information about regenerative medicine therapies, such as cell and gene therapy products, and explore opportunities for patients, care partners, and advocates to engage with FDA to help advance product development of OTP-regulated products. Leaders from across OTP will provide information about how the office is helping to advance cell and gene therapy product development through innovation, engagement, and collaboration. Further information on this event can be found here.

Published on the 9th of January 2025. Read the entire Regulatory Round-up – December 2024.


OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (12 février 2025). RegenMedEd roundtable with FDA’s office of therapeutic products (OTP) (from Catapult’s regulatory round-up for December 2024). ELSIBI. Consulté le 18 février 2026 à l’adresse https://doi.org/10.58079/13ay1


Vous aimerez aussi...

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *

This site uses Akismet to reduce spam. Learn how your comment data is processed.